7 completed, 6 unknown, 1 terminated. 4 Not applicable, 3 Phase 1, 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Unknown 1 |
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Hematological Disease: new trials by email Literature Review of Hematological Disease trials Research Report on Hematological Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hematological Disorder in Patients With Angiodysplasia Von willebrand antigen - Angiodysplasia, Hematological Disease | Unknown | Assiut University | 55 | 2024-06-01 | 2024-05-02 | |
| Some Hematological Profile in Children With Chronic Kidney Disease CKD, Hematological Disease | Unknown | Assiut University | 102 | 2024-03-01 | 2024-02-20 | |
| Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation Hetrombopag, placebo - Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation | Not applicable | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 78 | 2023-01-01 | 2023-02-14 |
| AI Algorithms to Automate the TMI by VMAT Optimization Using WB-CT/MRI and Synthetic WB-CT - The AuToMI Project Total Marrow (Lymph-node) Irradiation - Hematological Disease | Not applicable | Completed | Istituto Clinico Humanitas | 60 | 2021-06-15 | 2026-01-21 |
| XIENCE 28 Global Study XIENCE, DAPT - Bleeding Disorder, Stroke, Ischemic | Not applicable | Completed | Abbott Medical Devices | 963 | 2018-02-09 | 2021-03-04 |
| CMV-CTL for the Treatment of CMV Infection After HSCT donor derived cytomegalovirus specific T lymphocytes, Foscarnet, Ganciclovir - Cytomegalovirus Infections, Hematological Disease | Phase 4 | Completed | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 5 | 2016-11-01 | 2023-04-25 |
| URMC Related Haplo-identical Donor BMT Total Body Irradiation 1200 cGy, Fludarabine, Pre-Stem Cell Infusion Cyclophosphamide - Hematological Disease, Immune Deficiencies | Phase 1 | Completed | University of Rochester | 74 | 2015-10-01 | 2021-11-03 |
| Randomized Trial:the Effect of Liquid Food on the Intake of Energy and Protein in Malignant Hematologic Patients dietary counselling - Hematological Disease, Delayed Gastric Emptying | Not applicable | Completed | Jens Rikardt Andersen | 20 | 2015-03-01 | 2016-08-26 |
| Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards Oncology [See Also, Affected System], Hematological Disease | Unknown | University of Cologne | 2264 | 2015-01-01 | 2016-02-08 | |
| A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies Pelabresib, Ruxolitinib - Myelofibrosis, Leukemia, Myelocytic, Acute | Phase 1 / Phase 2 | Completed | Constellation Pharmaceuticals | 336 | 2014-07-16 | 2026-06-04 |
| Registry of Febrile Neutropenia and Invasive Fungal Infections Patient registry - Hematological Disease, Febrile Neutropenia | Unknown | Chang Gung Memorial Hospital | 100 | 2011-11-01 | 2012-09-12 | |
| Cord Blood Transplantation for Patients With Cancer Melphalan, Fludarabine, Antithymocyte Globulin (ATG) - Hematological Disease | Phase 2 | Terminated | University of Chicago | 1 | 2010-04-01 | 2015-04-30 |
| Exercise Following Autologous Peripheral Blood Stem Cell Transplantation Supervised exercise - Hematological Disease | Phase 3 | Unknown | Charite University, Berlin, Germany | 60 | 2009-12-01 | 2009-12-23 |
| Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies CHR-2845 - Hematological Disease, Lymphoid Malignancies | Phase 1 | Completed | Chroma Therapeutics | 18 | 2008-12-01 | 2011-11-28 |
Hematologic Diseases (14) · Neoplasms (2) · Primary Myelofibrosis (2) · Anemia (1) · Angiodysplasia (1) · Bone Marrow Diseases (1) · Coronary Artery Disease (1) · Cytomegalovirus Infections (1) · Fatigue (1) · Febrile Neutropenia (1) · Gastroparesis (1) · Hemorrhagic Stroke (1) · Hemostatic Disorders (1) · Ischemic Stroke (1) · Leukemia (1)
Hemic and Lymphatic Diseases (14) · Cardiovascular Diseases (3) · Hemorrhagic Disorders (3) · Vascular Diseases (3) · Blood Platelet Disorders (2) · Cytopenia (2) · Infections (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Agranulocytosis (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Bacterial Infections and Mycoses (1) · Behavior (1) · Blood Coagulation Disorders (1)
Busulfan (2) · Melphalan (2) · fludarabine (2) · Antilymphocyte Serum (1) · CHR 2845 (1) · CPI-0610 (1) · Foscarnet (1) · Ganciclovir (1) · Radiation (1) · Thiotepa (1) · Whole-Body Irradiation (1) · fludarabine phosphate (1) · hetrombopag (1) · ruxolitinib (1)
Assiut University (2) · Abbott Medical Devices (1) · Chang Gung Memorial Hospital (1) · Charite University, Berlin, Germany (1) · Chroma Therapeutics (1) · Constellation Pharmaceuticals (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Istituto Clinico Humanitas (1) · Jens Rikardt Andersen (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · University of Chicago (1) · University of Cologne (1) · University of Rochester (1)
Belgium (3) · China (3) · Germany (3) · Italy (3) · Netherlands (3) · United States (3) · France (2) · Taiwan (2) · United Kingdom (2) · Austria (1) · Canada (1) · Denmark (1) · Hong Kong (1) · Poland (1) · Portugal (1)
AbdelHamid Mohamed AbdelHamid Aly (1) · Andrew Artz, MD (1) · Asmaa Ahmed, lecture (1) · Erlie Jiang (1) · Fernando Dimeo, MD (1) · Gert Ossenkoppele, M.D (1) · Harald Seifert, Prof. Dr. (1) · Jeffrey Andolina, MD (1) · Jens R Andersen, Lektor (1) · Kotb Abbass, professor (1) · Liping Wan, M.D.，Ph.D. (1) · Marco Valgimigli, MD (1) · Maria JG Vehreschild, PD Dr. (1)
PMID 23647373, PMID 33031789, PMID 34794687, PMID 36881782, PMID 37530627, PMID 38259250, PMID 40512423
2018 (1)